Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00340158 · ClinicalTrials.gov registry record
Establishing an Inflammatory Breast Cancer Registry
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 164
- Enrollment target
NCT00340158: Completed study, sponsored by National Cancer Institute (NCI).
NCT00340158 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00340158 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
Inflammatory breast carcinoma (IBC) is an extremely rare, aggressive form of breast cancer that disproportionately impacts young women. IBC often affects the skin of the breast, as well as the breast itself, making it appear inflamed. The purpose of this study is to collect data and information on IBC patients so that researchers can study factors associated with IBC. The data and information collected will be used to establish the IBC Registry, a private cancer registry. Approximately 300 persons who are 18 years or older and who have been diagnosed with IBC will participate in this study. Participants will provide researchers with access to their medical and pathology records, slides, tissue, and x-rays. They also will consent to a 15-minute telephone interview concerning general information about themselves and the initial manifestation of IBC and to a 30-minute interview about their medical history.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2003-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00340158
The ClinicalTrials.gov registry entry for NCT00340158 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00340158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00340158 about?
NCT00340158 is a clinical study titled "Establishing an Inflammatory Breast Cancer Registry". Inflammatory breast carcinoma (IBC) is an extremely rare, aggressive form of breast cancer that disproportionately impacts young women. IBC often affects the skin of the breast, as well as the breast itself, making it appear inflamed. The purpose of this study is to collect data and information on I...
What is the current status of trial NCT00340158?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2003-06.
Who is sponsoring clinical trial NCT00340158?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.